Bellicum Pharmaceuticals, at work in oncology’s buzziest field, banked $140 million in an upsized, above-its-range IPO, stoking the fervor around cancer immunotherapies.

…read more

Source: Bellicum pulls off a $140M IPO as CAR-T has its day on Wall Street